Corbus Pharmaceuticals Holdings, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Corbus Pharmaceuticals Holdings, Inc. Return On Equity for the quarter ending June 30, 2024 was -64.8 %, a 64.6% increase year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Equity for 2023 was -920 %, a 908% decline from 2022.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Equity for 2022 was -91.3 %, a 57.6% decline from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Equity for 2021 was -57.9 %, a 81.1% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -920 -829 -908% Jan 1, 2023 Dec 31, 2023
2022 -91.3 -33.4 -57.6% Jan 1, 2022 Dec 31, 2022
2021 -57.9 +248 +81.1% Jan 1, 2021 Dec 31, 2021
2020 -306 -77.9 -34.2% Jan 1, 2020 Dec 31, 2020
2019 -228 -111 -95.8% Jan 1, 2019 Dec 31, 2019
2018 -116 -40.5 -53.3% Jan 1, 2018 Dec 31, 2018
2017 -75.9 +96.9 +56.1% Jan 1, 2017 Dec 31, 2017
2016 -173 -60.8 -54.3% Jan 1, 2016 Dec 31, 2016
2015 -112 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.